Product Images Atorvastatin Calcium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Atorvastatin Calcium NDC 70934-069 by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
70934 069 90 Rev A 01 19
This is a description of medication for Atorvastatin Calcium Tablets in 20mg strength. The medication is available in a package size of 20 tablets. The NDC number is 70934-068-90. The rest of the text appears to be incomplete or gibberish.*
Label 1 - 70934 070 30 Rev A 01 18
Chemical Structure - atorvastatin calcium tablets 1
Figure 1 - atorvastatin calcium tablets 2
The text appears to be a chart or diagram showing the cumulative incidence percentages for a certain time period. It also includes a hazard ratio (HR) and p-value. The exact context and interpretation of the data cannot be determined without further information.*
Figure 2 - atorvastatin calcium tablets 3
This is a graph that shows the cumulative hazard percentage over a period of 4 years based on a certain primary endpoint. The hazard percentages are shown for 5 different time points. The hazard ratio (HR) is also provided, which indicates a 37% decrease in the risk of the primary endpoint over the course of 4 years with a p-value of 0.001.*
Figure 3 - atorvastatin calcium tablets 4
The text describes a study in which subjects were given different doses of Atorvastatin (10mg and 80mg). The table given shows the percentage of subjects experiencing a cardiovascular event over time. The results suggest that the group given Atorvastatin 80mg had a lower risk of experiencing a cardiovascular event compared to the group given Atorvastatin 10mg. The hazard ratio and p-value for this difference are also given. However, given the limited information available, it is difficult to determine the specific cardiovascular outcomes or characteristics of the study population.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.